BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2574893)

  • 61. Antipsychotic drug use in the United States, 1976-1985.
    Wysowski DK; Baum C
    Arch Gen Psychiatry; 1989 Oct; 46(10):929-32. PubMed ID: 2572207
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A double blind comparative trial of pericyazine and thioridazine in chronic schizophrenia.
    Barker JC; Miller M
    Br J Psychiatry; 1969 Feb; 115(519):169-72. PubMed ID: 4888133
    [No Abstract]   [Full Text] [Related]  

  • 63. Increased serum prolactin levels during phenothiazine and butyrophenone treatment of six postpartum women.
    Goode DJ; Meltzer HY; Fang VS
    Psychoneuroendocrinology; 1980 Dec; 5(4):345-51. PubMed ID: 6111101
    [No Abstract]   [Full Text] [Related]  

  • 64. An overview of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study.
    McEvoy JP
    CNS Spectr; 2006 Jul; 11(7 Suppl 7):4-8. PubMed ID: 16816794
    [No Abstract]   [Full Text] [Related]  

  • 65. Piperacetazine versus thioridazine in the treatment of organic brain disease: a controlled double-blind study.
    Goldstein SE; Birnbom F
    J Am Geriatr Soc; 1976 Aug; 24(8):355-8. PubMed ID: 7588
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Drugs against schizophrenia: SBU fails to sort things out].
    Thelander S
    Lakartidningen; 2012 Aug 8-21; 109(32-33):1417; author reply 1418-9. PubMed ID: 22953431
    [No Abstract]   [Full Text] [Related]  

  • 67. [FDA phase II and phase III drug evaluation of antipsychotic agents].
    Yagi K
    Seishin Shinkeigaku Zasshi; 1990; 92(9):584-92. PubMed ID: 1980369
    [No Abstract]   [Full Text] [Related]  

  • 68. Discontinuation of thioridazine. What happened to thioridazine?
    Arshad P; Morcos M; Sridharan B
    BMJ; 2002 Oct; 325(7370):967. PubMed ID: 12402926
    [No Abstract]   [Full Text] [Related]  

  • 69. [Treatment of chorea (author's transl)].
    Murai Y; Yoshida M; Yanagisawa N
    Rinsho Shinkeigaku; 1977 Dec; 17(12):811-5. PubMed ID: 24511
    [No Abstract]   [Full Text] [Related]  

  • 70. [Experience with haloperidol and thioridazine in stuttering children].
    Valdivieso A
    Rev Chil Pediatr; 1974; 45(6):509-11. PubMed ID: 4467233
    [No Abstract]   [Full Text] [Related]  

  • 71. Prophylactic effects of neuroleptics in symptom-free schizophrenics: roles of dopaminergic and noradrenergic blockers.
    Nishikawa T; Tsuda A; Tanaka M; Koga I; Uchida Y
    Biol Psychiatry; 1985 Nov; 20(11):1161-6. PubMed ID: 3902105
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Blood level measurement of psychoactive drugs in pediatric psychiatry.
    Gualtieri CT; Golden R; Evans RW; Hicks RE
    Ther Drug Monit; 1984; 6(2):127-41. PubMed ID: 6146213
    [No Abstract]   [Full Text] [Related]  

  • 73. Pharmacological treatment of self-injurious behavior in mentally retarded persons.
    Singh NN; Millichamp CJ
    J Autism Dev Disord; 1985 Sep; 15(3):257-67. PubMed ID: 2863252
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Stages of schizophrenic decompensation and reintegration.
    Donlon PT; Blacker KH
    J Nerv Ment Dis; 1973 Sep; 157(3):200-9. PubMed ID: 4146931
    [No Abstract]   [Full Text] [Related]  

  • 75. Schneiderian first-rank symptoms and clinical prognostic features in schizophrenia.
    Taylor MA
    Arch Gen Psychiatry; 1972 Jan; 26(1):64-7. PubMed ID: 5009429
    [No Abstract]   [Full Text] [Related]  

  • 76. Effects of Curcumin on Cognitive Functioning and Inflammatory State in Schizophrenia: A Double-Blind, Placebo-Controlled Pilot Trial.
    Kucukgoncu S; Guloksuz S; Tek C
    J Clin Psychopharmacol; 2019; 39(2):182-184. PubMed ID: 30747752
    [No Abstract]   [Full Text] [Related]  

  • 77. Haloperidol, thioridazine and placebo in mentally subnormal patients-serum levels and clinical effects.
    Väisänen K; Viukari M; Rimón R; Räisänen P
    Acta Psychiatr Scand; 1981 Mar; 63(3):262-71. PubMed ID: 7015792
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Impact of the CSM advice on thioridazine on general practitioner prescribing behaviour in Leeds: time series analysis.
    Wright NM; Roberts AJ; Allgar VL; Tompkins CN; Greenwood DC; Laurence G
    Br J Gen Pract; 2004 May; 54(502):370-3. PubMed ID: 15113522
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Plasma neuroleptic and prolactin levels in mentally retarded patients.
    Linnolia M; Viukari M; Vaisanen K; Auvinen J
    Acta Pharmacol Toxicol (Copenh); 1980 Feb; 46(2):159-60. PubMed ID: 6102427
    [No Abstract]   [Full Text] [Related]  

  • 80. Behavioral correlates of the guessing game. Side effects and double-blind studies.
    Ohler J; Grinspoon L; Shader R; Chatterjee S
    Arch Gen Psychiatry; 1966 Sep; 15(3):279-87. PubMed ID: 5330061
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.